In this issue:
TIL of ipilimumab in advanced Melanoma
Pembrolizumab versus placebo as adjuvant therapy
Dabrafenib and trametinib vs nivolumab and ipilimumab in melanoma
Safety and efficacy of nivolumab
Phase 1b of cobimetinib plus atezolizumab in wild-type melanoma
Alcohol consumption and risk of skin cancer
Ultrasound and SRT or external beam radiotherapy for epithelial cancer
Same day biopsy and treatment for non-melanoma skin cancer
Disparities in melanoma-specific mortality
Ambiguous melanocytic lesions
Please login below to download this issue (PDF)